F Hitz
Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial
Hitz F, Mey U, Zucca E, Berardi Vilei S, Eckhardt K, Berthod G, Caspar C, Pabst T, Fischer N, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial. Ann Hematol 2013; 92:1033-40.
17.04.2013Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial
17.04.2013Ann Hematol 2013; 92:1033-40
Hitz F, Mey U, Zucca E, Berardi Vilei S, Eckhardt K, Berthod G, Caspar C, Pabst Th, Fischer N, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis
Vehoff J, Hundsberger T, Hitz F, Tettenborn B (2007). Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis.
01.01.2007Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis
01.01.2007-
Vehoff Jochen, Hundsberger Thomas, Hitz F, Tettenborn Barbara
Acute pericarditis and pleural effusion complicating cytarabine chemotherapy
Gähler A, Hitz F, Hess U, Cerny T. Acute pericarditis and pleural effusion complicating cytarabine chemotherapy. Onkologie 2003; 26:348-50.
01.08.2003Acute pericarditis and pleural effusion complicating cytarabine chemotherapy
01.08.2003Onkologie 2003; 26:348-50
Gähler A, Hitz F, Hess U, Cerny Thomas